Recruiting NCT06898879
This study is looking at whether a digital support tool can help people with depression, psychosis, or bipolarity. Participants take part in a digital support tool and complete follow-up assessments.
In Albuquerque Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Depression, ... Behavioral Over 18 Years
Countries United States
Sponsor VA Office of Research and Development
Condition Schizophrenia, Depression, ... Recruiting NCT06740890
This study is looking at whether Olanzapine-samidorphan + exercise can help people with Schizophenia Disorder, schizoaffective disorder, bipolarity I or II, or bipolarity NOS. Participants receive a study treatment and complete follow-up visits and assessments.
In New York Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Bipolarity Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States
Sponsor New York State Psychiatric Institute
Condition Schizophrenia, Bipolarity Recruiting NCT07234708
This summary needs review. Please check the official study record and contact the research team for details.
In Barcelona Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral Over 18 Years
Countries Spain
Sponsor Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Condition Schizophrenia Recruiting NCT06286202
This summary needs review. Please check the official study record and contact the research team for details.
In Singapore Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 21 Years to 60 Years
Countries Singapore
Sponsor Singapore Institute of Technology
Condition Schizophrenia Recruiting NCT07085923
This summary needs review. Please check the official study record and contact the research team for details.
In Oslo Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Bipolarity Behavioral From 25 Years to 70 Years
Countries Norway
Sponsor Madeleine Elisabeth Angelsen
Condition Schizophrenia, Bipolarity Recruiting NCT04945278
This summary needs review. Please check the official study record and contact the research team for details.
In Bohars Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other From 15 Years to 25 Years
Countries France
Sponsor University Hospital, Brest
Condition Schizophrenia Recruiting NCT07696000
This summary needs review. Please check the official study record and contact the research team for details.
In Medan Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other From 18 Years to 60 Years
Countries Indonesia
Sponsor DINA KEUMALA SARI
Condition Schizophrenia Recruiting NCT06005766
This summary needs review. Please check the official study record and contact the research team for details.
In Vaasa Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Depression Behavioral Over 18 Years
Countries Finland
Sponsor University of Jyvaskyla
Condition Schizophrenia, Depression Recruiting NCT06650943
This summary needs review. Please check the official study record and contact the research team for details.
In Bilbao Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral
Countries Spain
Sponsor Hospital de Basurto
Condition Schizophrenia Recruiting NCT07616999
This summary needs review. Please check the official study record and contact the research team for details.
In Hong Kong Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Observational i A study where researchers collect information without assigning a treatment. From 18 Years to 65 Years
Countries China
Sponsor The University of Hong Kong
Condition Schizophrenia Recruiting NCT06585787
The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Belgium, ...
Multiple locations, including Gilbert Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 55 Years to 90 Years
Countries United States, France, Belgium, ...
Sponsor Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition Schizophrenia Recruiting NCT07231497
This summary needs review. Please check the official study record and contact the research team for details.
In Minneapolis Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 35 Years
Countries United States
Sponsor University of Minnesota
Condition Schizophrenia